Biovie is trading 11.59% up at $2.41 after four insiders reported open-market purchases following the August 28 session.
- CEO Cuong V. Do bought 15,210 shares worth $31,636.
- The CFO, CMO, and a director also purchased shares.
- The four insiders collectively bought approximately $49,118, with the concentrated activity appearing to be the primary company-specific catalyst behind the August 31 advance.